Lifeward CEO Issues Year-End 2024 Open Letter to Shareholders and Provides 2025 Commercial and Operational Priorities
01/13/25
Lifeward Announces Closing of $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
01/08/25
Lifeward Announces $5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
01/07/25
Lifeward Announces Postponement of its Extraordinary General Meeting of Shareholders
12/27/24
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
11/19/24
Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies
11/04/24
Displaying 1 - 12 of 304